Xenotransplantation is this the future?

Seminars in Nephrology

Volumn 20, Issue 2, 2000, Pages 217-229

  Hancock, Wayne W ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN;

COMPLEMENT ACTIVATION; GENETIC ENGINEERING; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SPECIES DIFFERENCE; XENOTRANSPLANTATION; ZOONOSIS;

ACUTE DISEASE; ANIMALS; GRAFT REJECTION; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TRANSPLANTATION, HETEROLOGOUS; ZOONOSES;

EID: 0034018320     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hancock WW: The past, present and future of renal xenotransplantation. Kidney Int 51:932-944, 1997
2. Hancock WW: Beyond hyperacute rejection: Strategies for development of pig-primate xenotransplantation. Kidney Int 51:S36-S40, 1997
3. Hancock WW: The business of xenotransplantation. Am Soc Transplant Phys News 4:1-4, 1997
4. Reemtsma K: Xenotransplantation: A personal history, in Hardy MA (ed): Xenograft 25. Amsterdam, The Netherlands, Elsevier Science, 1989, pp 7-16
5. Starzl TE, Valdivia LA, Murase N, et al: The biological basis and strategies for clinical xenotransplantation. Immunol Rev 141:213-244, 1994
6. Fishman JA: Infection and xenotransplantation. Developing strategies to minimize risk. Ann N Y Acad Sci 862:52-66, 1998
7. Paradis K, Langford G, Long Z, et al: Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living tissue. Science 285:1236-1241, 1999
8. Weiss R: Xenografts and retroviruses. Science 285:1221-1222, 1999
9. Calne RY: Organ transplantation between widely disparate species. Transplant Proc 2:550-556, 1970
10. Makowka L, Cramer DV, Hoffman A, et al: Pig liver xenografting as a temporary bridge for human allografting. Graft 1:27-29, 1993
11. Galili U: Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunol Today 14:480-482, 1993
12. d'Apice AJF, Tange MJ, Chao-Guang C, et al: Gal(α1,3)Gal: elimination, suppression, masking or none of the above? Xeno 3:113-116, 1995
13. Chen CG, Salvaris EJ, Romanella M, et al: Transgenic expression of human alphal,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection. Transplantation 65:832-837, 1998
14. Hancock WW: Immunopathology of discordant xenograft rejection, in Cooper DKC, Kemp E, Platt JL, White DJG (eds): Xenotransplantation: The Transplantation of Organs and Tissues Between Species. Berlin, Springer-Verlag, 1997, pp 303-313
15. Kobayashi T, Neethling FA, Taniguchi S, et al: Investigation of the anti-complement agents, FUT-175 and K76COOH, in discordant xenotransplantation. Xenotransplantation 3:237-245, 1996
16. Miyagawa S, Hirose H, Shirakura R, et al: The mechanism of discordant xenograft rejection. Transplantation 46:825-830, 1988
17. Koyamada N, Miyatake T, Candinas D, et al: Apyrase administration prolongs discordant xenograft survival. Transplantation 62:1739-1743, 1996
18. Candinas D, Lesnikoski BA, Hancock WW, et al: Inhibition of platelet integrin GPIIb/IIIa prolongs survival of discordant cardiac xenografts. Transplantation 62:1-5, 1996
19. Bach F, Robson SC, Hancock WW, et al: Endothelial activation is a barrier to xenotransplantation. Nature Med 1:869-873, 1995
20. Robson SC, Young VK, Cook NS, et al: Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection. Transplantation 61:862-868, 1996
21. Kobayashi T, Taniguchi S, Neethling FA, et al: Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 64:1255-1261, 1997
22. Simon P, Neethling FA, Taniguchi S, et al: Intravenous infusion of galα1-3gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation 65:346-353, 1998
23. Cozzi E, White DJG: The generation of transgenic pigs as potential organ donors for humans. Nature Med 1:964-966, 1995
24. Lin SS, Weidner BC, Byrne GW, et al: The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 101:1745-56, 1998
25. Hancock WW: Delayed xenograft rejection. World J Surgery 21:917-923, 1997
26. Blakely ML, van der Werf W, Berndt M, et al: Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 58:1059-1066, 1994
27. Candinas D, Koyamada N, Miyatake T, et al: T cell-independence of macrophage and NK cell infiltration, cytokine production and endothelial activation during delayed xenograft rejection. Transplantation 62:1920-1926, 1996
28. Hancock WW, Tran TH, Kao J: Induction of protective gene expression within graft endothelial cells as a means to control NFκB activation and development of chronic rejection. Graft 1:21-24, 1998 (suppl II)
29. Hancock WW, Miyatake T, Koyamada N, et al: Effects of leflunomide and deoxyspergualin in the guinea pig-rat cardiac model of delayed xenograft rejection: Suppression of B cell and C-C chemokine responses but not induction of macrophage lectin. Transplantation 64:696-704, 1997
30. lerino FL, Gojo S, Banerjee PT, et al: Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers. Transplantation 67:1119-28, 1999